Venus Remedies Limited Paclitaxel Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Paclitaxel Export Records India — #6 Exporter, 220 Shipments, $3.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Paclitaxel

India Pharmaceutical Trade Intelligence

$83.1M319 Suppliers142 CountriesHS 30049044

ExportsIndia → GERMANY20.6%India → UNITED STATES13.1%

ImportsSOUTH KOREA → India$1.6B UNITED STATES → India$2.3M

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Venus Remedies Limited — Paclitaxel Exporter #6 | $3.2M Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Paclitaxel Exporter Profile

Indian Pharmaceutical Exporter · #6 for Paclitaxel · $3.2M export value · DGFT Verified

Venus Remedies Limited is the #6 Indian exporter of Paclitaxel with $3.2M in export value and 220 verified shipments. Venus Remedies Limited holds a 3.8% market share in Paclitaxel exports across 18 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Paclitaxel Export Profile: Buyers & Destinations

Venus Remedies Limited Paclitaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Paclitaxel?

Country	Value	Shipments	Share
COLOMBIA	$802.1K	41	28.5%
MOROCCO	$646.1K	29	22.9%
THAILAND	$409.6K	29	14.5%
MALAYSIA	$231.6K	13	8.2%

Who Are the Top Buyers of Paclitaxel from Venus Remedies Limited?

Buyer	Country	Value	Orders
P P	MOROCCO	$300.1K	10
PHARMAPROM	MOROCCO	$247.0K	17
C M C L	THAILAND	$177.2K	11
HB HUMAN BIOSCIENCE S.A.S	COLOMBIA	$174.9K	5
A S A S	COLOMBIA	$116.1K	6
ALPHARMA S.A.S.	COLOMBIA	$112.7K	8
U S B	MALAYSIA	$100.2K	4
UNIMED SDN BHD	MALAYSIA	$95.9K	7
ALPHARMA S A S	COLOMBIA	$92.2K	5
H H B S	COLOMBIA	$84.4K	3

Venus Remedies Limited supplies Paclitaxel to 71 buyers globally. The largest buyer is P P (MOROCCO), followed by PHARMAPROM (MOROCCO) and C M C L (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Paclitaxel Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
PACLITAXEL INJECTION USP 100MG/16.7ML EA	$137.3K	6
PACLITAXEL INJECTION USP 30MG/5ML (PACLITOL 30 MG)	$100.0K	2
YUTAXAN PACLITAXEL INJECTABLE SOLUTION	$82.8K	3
PACLITAXEL INJECTION USP 30MG/5ML PACLITOL 30MG BN.X4BPA161A, X4BPA221A, X4BPA231A, X4BPA241A, MD.02/2024,ED.01/2026	$81.5K	3
PACLITAXEL INJECTION USP 30MG/5ML EACH M	$61.3K	6
PACLITAXEL INJECTION USP 30MG/5ML. PACLITOL 30MG.B.NO.X4APA011AX4APA041AX4APA051AX4APA061AX4APA071A.MD.1/24 ED.12/25NOS	$60.7K	3
PACLITAXEL INJECTION USP 100MG/16.7ML.EA	$56.5K	2
PACLITOL PACLITAXEL INJECTION USP30 MG/5 M L EACH ML CONTAINS: PACLITAXEL USP.... .... .. ... ...6MG	$50.0K	1
PACLITAXEL SOLUTION FOR INJECTION 100 MG/16.7 ML.PACLITAXEL 100MG.B.NO.X4BPA182DMFG.DT.02/2024EXP.DT.01/2026	$50.0K	1
PACLITAXEL INJECTION USP (30 MG/5 ML) PACLITOL 30MG. B.NO.X4EPA031A MD.05/2024,ED.04/2026.	$50.0K	1

Venus Remedies Limited exports 187 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PACLITAXEL INJECTION USP 100MG/16.7ML EA with 6 shipments worth $137.3K.

How Does Venus Remedies Limited Compare to Nearest Paclitaxel Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	INTAS PHARMACEUTICALS LIMITED	$5.9M	405	19	$14.7K
5	PANACEA BIOTEC PHARMA LIMITED	$3.3M	65	15	$50.0K
6	VENUS REMEDIES LIMITED ★	$3.2M	220	18	$14.4K
4	JODAS EXPOIM PRIVATE LIMITED	$3.1M	63	2	$50.0K
9	KARDI TRADING PRIVATE LIMITED	$2.4M	83	7	$29.3K

Venus Remedies Limited ranks #6 among 319 Indian Paclitaxel exporters. Average shipment value of $14.4K compared to the market average of $192.6K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and PANACEA BIOTEC PHARMA LIMITED.

Which Indian Ports Ship Paclitaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	830	16.8%
SAHAR AIR	614	12.5%
DELHI AIR	599	12.2%
SAHAR AIR CARGO ACC (INBOM4)	554	11.2%
HYDERABAD AIR	186	3.8%
AHEMDABAD AIR	183	3.7%
Bombay Air	172	3.5%
HYDERABAD ACC (INHYD4)	160	3.2%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Paclitaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 235 individual customs records matching Venus Remedies Limited exporting Paclitaxel, covering 187 formulations to 18 countries via 71 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 142+ countries, 959+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Paclitaxel

Paclitaxel

Venus Remedies Limited — Paclitaxel Exporter Profile

Venus Remedies Limited — Paclitaxel Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Paclitaxel?

Who Are the Top Buyers of Paclitaxel from Venus Remedies Limited?

What Is India's Total Paclitaxel Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Paclitaxel Exports?

How Does Venus Remedies Limited Compare to Other Indian Paclitaxel Exporters?

What Paclitaxel Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Paclitaxel Exporters?

Which Indian Ports Ship Paclitaxel Exports?

What Other Oncology Products Does Venus Remedies Limited Export?

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Paclitaxel Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Paclitaxel Export Data from Venus Remedies Limited

Paclitaxel Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source